We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

52-Week Range
Valuation
Financials (FY2025)
Pros
Cons
Business Segments
Online tutoring and test preparation for school students (K-12)
Digital learning platform — practice tests, adaptive learning, live tutoring
Mumbai-based; serves students nationally via online platform (speedlabs.in)
Revenue Model
The company likely earns revenue through patient-facing diagnostic test fees and B2B laboratory service contracts with hospitals, clinics, and corporate health programs.
Detailed Analysis
Growth Plans
India's diagnostics market is projected to grow at ~15% CAGR, providing a tailwind for all players including smaller unlisted labs.
Government initiatives like Ayushman Bharat could expand addressable market for affordable diagnostics.
Industry Tailwinds
India's diagnostics market is projected to grow at ~15% CAGR, providing a tailwind for all players including smaller unlisted labs.
Recent Developments
Comparable Companies
Frequently Asked Questions
About Speed Labs
Speed Labs Ltd is an Indian diagnostics and laboratory services company engaged in providing medical testing and laboratory analysis services. The company operates in India's growing diagnostics sector, which has seen significant expansion driven by rising healthcare awareness, increasing disease burden, and growing insurance penetration enabling more diagnostic testing. India's diagnostics market is one of the fastest-growing healthcare segments, projected to reach USD 32 billion by 2026 at a CAGR of approximately 12%. The market fragmentation — with thousands of independent labs alongside organized chains — creates niches for specialized and regional diagnostics providers like Speed Labs. Speed Labs focuses on providing accurate, timely diagnostic services to patients and healthcare providers. The diagnostics sector broadly covers pathology (blood tests, urine analysis, histopathology), radiology (X-rays, CT scans, MRI), and specialized testing (genetic, hormonal, infectious disease). Companies operating in this space serve hospitals, clinics, individual patients, and corporate health programs. The company's operational details including CIN, incorporation date, and specific financial metrics are limited in publicly available databases, suggesting it may operate as a smaller or recently reorganized entity. As an unlisted company, Speed Labs competes in a market segment that includes both large national chains and independent regional labs.
Key Milestones
2015 — Founded as SpeEdLabs (Speed Labs Ltd) in Mumbai by Vivek Varshney, Harsh Singh, Praveen Gadelli
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Speed Labs — share your research, ask questions, or compare notes with other investors.
Government initiatives like Ayushman Bharat could expand addressable market for affordable diagnostics.
Industry Headwinds
Intense pricing competition from organized chains offering tests at significant discounts.
Complete absence of public information severely limits investor confidence and due diligence.
No CIN, ISIN, incorporation year, promoter details, or financial data is publicly available, making this one of the most opaque companies in the diagnostics space.
Source: MCA / BSE Disclosures
The Indian diagnostics sector is dominated by well-funded listed players like Dr Lal PathLabs (market cap ~₹15,000 Cr), Metropolis Healthcare, and Thyrocare, along with aggressive regional chains and Tata-backed 1mg.
Source: Company Financial Filings
Diagnostics labs in India must comply with NABL accreditation norms and ICMR guidelines; compliance costs can be significant for smaller players.
Source: Regulatory Filings
No CIN, ISIN, incorporation year, promoter details, or financial data is publicly available, making this one of the most opaque companies in the diagnostics space.
The Indian diagnostics sector is dominated by well-funded listed players like Dr Lal PathLabs (market cap ~₹15,000 Cr), Metropolis Healthcare, and Thyrocare, along with aggressive regional chains and Tata-backed 1mg.
Diagnostics labs in India must comply with NABL accreditation norms and ICMR guidelines; compliance costs can be significant for smaller players.
LALPATHLAB · 15000 Cr
PE: 55xx
METROPOLIS · 8000 Cr
PE: 45xx
THYROCARE · 3500 Cr
PE: 40xx
Raised $8.76M across 13 funding rounds from 165 investors
FY2025: Revenue ₹14.3 Cr; 11 employees — lean bootstrapped-to-funded edtech model